-
Health todayCancer refines
Interval colorectal cancer after negative FIT rises with faecal haemoglobin level
Faecal haemoglobin just below the 20 µg/g positive cut-off was associated with 15 times the interval cancer hazard of 0-5 µg/g.
Preprint · not peer-reviewed -
Data, models and systemsValue in health new
Capivasertib with abiraterone: modelled $3,120,720 per QALY in PTEN-deficient mHSPC
In a US payer model, capivasertib plus abiraterone for PTEN-deficient mHSPC cost $3,120,720 per QALY gained.
Peer-reviewed -
Data, models and systemsAI in medicine new
SPARC transformer model uses routine measurements to predict cancer adverse events
A transformer model trained on 224,047 patients' routine measurements predicted cancer adverse events in prospective and external cohorts.
Preprint · not peer-reviewed -
Health todayCancer refines
Colorectal cancer incidence in the US rose in 2023 after two decades of decline
US colorectal cancer incidence fell from 55.2 per 100,000 in 2000 to 36.7 in 2022, rising to 38.3 in 2023.
Peer-reviewed -
Health todayCancer refines
Mental health disorders and breast and bowel cancer screening and stage in Taiwan
In Taiwan, people with mental health disorders screened slightly more for breast and bowel cancer; severe cases screened less.
Peer-reviewed -
Health todayCancer refines
Lung adenocarcinoma across the COVID-19 era: small stage shifts, longer treatment delays
Lung adenocarcinoma stage barely shifted across the COVID-19 era, but treatment delays over 90 days rose from 10.2% to 14.5%.
Peer-reviewed -
Health todayCancer refines
Obesity in Korean adults aged 20 to 39 and risk of early-onset cancer into midlife
Ten-year cancer incidence among young Korean adults was 1.84% at normal weight and 2.62% in class II obesity.
Peer-reviewed -
Health todayCancer new
Cancer risk in first-generation migrants varies by birth country and cancer site in Europe
In European migrants, cervical, stomach and liver cancer risk rose with birth-country incidence; breast and colorectal risk was lower.
Preprint · not peer-reviewed -
Health todayCancer new
Off-label oncology drug use spans over a third of reimbursable Dutch drug–cancer pairings
In 2023 a quarter of Dutch high-cost cancer drug prescriptions were off-label, but they made up 2.3% of spending.
Peer-reviewed -
Data, models and systemsValue in health contradicts
Polygenic risk-guided prostate cancer screening was not cost-effective in a UK model
In a UK-calibrated microsimulation, prostate cancer screening guided by polygenic risk scores cost more and was less effective than alternatives.
Peer-reviewed -
Health todayCancer confirms
Head and neck cancer in New Zealand: rising oropharyngeal rates and unequal early deaths
New Zealand oropharyngeal cancer rates rose in 2009-2020, with higher two-year deaths for Māori, Pacific Peoples and the most deprived.
Peer-reviewed -
Data, models and systemsValue in health new
HPV catch-up vaccination to age 30 modelled in 132 low- and middle-income countries
A one-time catch-up campaign for females aged 9-30 was projected to prevent 6.93 million cervical cancer cases and 3.56 million deaths.
Preprint · not peer-reviewed